Memantine protects the cultured rat hippocampal neurons treated by NMDA and amyloid β1–42

Nataliia M. Rozumna, Vita V. Hanzha, Elena A. Lukyanetz · 2023

Read Memantine protects the cultured rat hippocampal neurons treated by NMDA and amyloid β1–42 by Nataliia M. Rozumna, Vita V. Hanzha, Elena A. Lukyanetz (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10748420.txt.

Description

Nataliia Rozumna, Vita Hanzha, and Elena Lukyanetz published a 2023 cell study of memantine, a drug that blocks NMDA receptors, against two toxins tied to Alzheimer's disease. Overactive NMDA receptors can excite neurons to death, a process suspected in the disease. The team cultured rat hippocampus neurons and exposed them for a day to NMDA itself or to amyloid beta, the protein fragment that builds up in Alzheimer's brains.

Either toxin more than doubled the share of dying neurons. Adding memantine alongside kept many more cells alive. The authors say the result supports memantine's protective role against this kind of excitotoxic damage. They also praise hippocampal cultures as a handy testbed for screening Alzheimer's treatments. The work is early and in dishes, not patients.

Catalog record

CREATORNataliia M. Rozumna, Vita V. Hanzha, Elena A. Lukyanetz
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE35 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10748420

Browse the full library · About the Tower of Babel